---
document_datetime: 2025-11-23 13:57:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/bondenza.html
document_name: bondenza.html
version: success
processing_time: 0.1049029
conversion_datetime: 2025-12-25 00:49:44.699768
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Bondenza (previously Ibandronic Acid Roche)

[RSS](/en/individual-human-medicine.xml/66217)

##### Withdrawn

This medicine's authorisation has been withdrawn

ibandronic acid

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Bondenza (previously Ibandronic Acid Roche)](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 23 February 2004, the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Bondenza, (ibandronic acid), which had been approved for treatment of osteoporosis in postmenopausal women at increased risk of fracture.

The marketing authorisation holder (MAH) responsible for Bondenza was Roche Registration Ltd. On 27 March 2013, the European Commission issued a decision to withdraw the marketing authorisation for Bondenza, following its receipt of a letter dated 14 February 2013 notifying the Commission of the MAH's decision to voluntarily withdraw the marketing authorisation for this product for commercial reasons.

Bondenza 150 mg film-coated tablets (Bondenza tablets) were marketed in the following European countries: Spain Bondenza 3 mg solution for injection (Bondenza IV) was not marketed in any European country.

Pursuant to this decision, the European public assessment report for Bondenza is updated to reflect that the marketing authorisation is no longer valid.

Bondenza : EPAR - Summary for the public

English (EN) (563.91 KB - PDF)

**First published:** 20/03/2009

**Last updated:** 13/05/2013

[View](/en/documents/overview/bondenza-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-18)

български (BG) (652.81 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/bg/documents/overview/bondenza-epar-summary-public_bg.pdf)

español (ES) (567.59 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/es/documents/overview/bondenza-epar-summary-public_es.pdf)

čeština (CS) (631.04 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/cs/documents/overview/bondenza-epar-summary-public_cs.pdf)

dansk (DA) (563.97 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/da/documents/overview/bondenza-epar-summary-public_da.pdf)

Deutsch (DE) (567.08 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/de/documents/overview/bondenza-epar-summary-public_de.pdf)

eesti keel (ET) (563.49 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/et/documents/overview/bondenza-epar-summary-public_et.pdf)

ελληνικά (EL) (659.1 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/el/documents/overview/bondenza-epar-summary-public_el.pdf)

français (FR) (568.28 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/fr/documents/overview/bondenza-epar-summary-public_fr.pdf)

italiano (IT) (564.92 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/it/documents/overview/bondenza-epar-summary-public_it.pdf)

latviešu valoda (LV) (669.16 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/lv/documents/overview/bondenza-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (591.9 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/lt/documents/overview/bondenza-epar-summary-public_lt.pdf)

magyar (HU) (627.12 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/hu/documents/overview/bondenza-epar-summary-public_hu.pdf)

Malti (MT) (648.18 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/mt/documents/overview/bondenza-epar-summary-public_mt.pdf)

Nederlands (NL) (567.18 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/nl/documents/overview/bondenza-epar-summary-public_nl.pdf)

polski (PL) (631.49 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/pl/documents/overview/bondenza-epar-summary-public_pl.pdf)

português (PT) (568.59 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/pt/documents/overview/bondenza-epar-summary-public_pt.pdf)

română (RO) (590.66 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/ro/documents/overview/bondenza-epar-summary-public_ro.pdf)

slovenčina (SK) (630.75 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/sk/documents/overview/bondenza-epar-summary-public_sk.pdf)

slovenščina (SL) (619.77 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/sl/documents/overview/bondenza-epar-summary-public_sl.pdf)

Suomi (FI) (567.23 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/fi/documents/overview/bondenza-epar-summary-public_fi.pdf)

svenska (SV) (565.28 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/sv/documents/overview/bondenza-epar-summary-public_sv.pdf)

## Product information

Bondenza : EPAR - Product Information

English (EN) (1.11 MB - PDF)

**First published:** 04/09/2009

**Last updated:** 13/05/2013

[View](/en/documents/product-information/bondenza-epar-product-information_en.pdf)

[Other languages (23)](#file-language-dropdown-169)

български (BG) (2.55 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/bg/documents/product-information/bondenza-epar-product-information_bg.pdf)

español (ES) (1.14 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/es/documents/product-information/bondenza-epar-product-information_es.pdf)

čeština (CS) (1.92 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/cs/documents/product-information/bondenza-epar-product-information_cs.pdf)

dansk (DA) (1.14 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/da/documents/product-information/bondenza-epar-product-information_da.pdf)

Deutsch (DE) (1.08 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/de/documents/product-information/bondenza-epar-product-information_de.pdf)

eesti keel (ET) (1.04 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/et/documents/product-information/bondenza-epar-product-information_et.pdf)

ελληνικά (EL) (2.52 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/el/documents/product-information/bondenza-epar-product-information_el.pdf)

français (FR) (1.08 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/fr/documents/product-information/bondenza-epar-product-information_fr.pdf)

íslenska (IS) (1.05 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/is/documents/product-information/bondenza-epar-product-information_is.pdf)

italiano (IT) (1.06 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/it/documents/product-information/bondenza-epar-product-information_it.pdf)

latviešu valoda (LV) (2.05 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/lv/documents/product-information/bondenza-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.27 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/lt/documents/product-information/bondenza-epar-product-information_lt.pdf)

magyar (HU) (1.88 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/hu/documents/product-information/bondenza-epar-product-information_hu.pdf)

Malti (MT) (2.01 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/mt/documents/product-information/bondenza-epar-product-information_mt.pdf)

Nederlands (NL) (1.13 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/nl/documents/product-information/bondenza-epar-product-information_nl.pdf)

norsk (NO) (1.13 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/no/documents/product-information/bondenza-epar-product-information_no.pdf)

polski (PL) (1.94 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/pl/documents/product-information/bondenza-epar-product-information_pl.pdf)

português (PT) (1.26 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/pt/documents/product-information/bondenza-epar-product-information_pt.pdf)

română (RO) (1.24 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/ro/documents/product-information/bondenza-epar-product-information_ro.pdf)

slovenčina (SK) (1.92 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/sk/documents/product-information/bondenza-epar-product-information_sk.pdf)

slovenščina (SL) (1.85 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/sl/documents/product-information/bondenza-epar-product-information_sl.pdf)

Suomi (FI) (1.05 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/fi/documents/product-information/bondenza-epar-product-information_fi.pdf)

svenska (SV) (1.12 MB - PDF)

**First published:**

04/09/2009

**Last updated:**

13/05/2013

[View](/sv/documents/product-information/bondenza-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0034 15/11/2012

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Bondenza : EPAR - All Authorised presentations

English (EN) (477.15 KB - PDF)

**First published:** 20/03/2009

**Last updated:** 13/05/2013

[View](/en/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-457)

български (BG) (570.06 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/bg/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_bg.pdf)

español (ES) (477.8 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/es/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_es.pdf)

čeština (CS) (560.02 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/cs/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (477.58 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/da/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (477.71 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/de/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (478.18 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/et/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (561.13 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/el/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_el.pdf)

français (FR) (478.24 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/fr/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (476.74 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/it/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (558.83 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/lv/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (545.31 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/lt/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (556.04 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/hu/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (561.81 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/mt/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (476.95 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/nl/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_nl.pdf)

polski (PL) (560.05 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/pl/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_pl.pdf)

português (PT) (477.51 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/pt/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_pt.pdf)

română (RO) (546.57 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/ro/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (555.85 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/sk/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (489.09 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/sl/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (477.42 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/fi/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (477.35 KB - PDF)

**First published:**

20/03/2009

**Last updated:**

13/05/2013

[View](/sv/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Bondenza (previously Ibandronic Acid Roche) Active substance ibandronic acid International non-proprietary name (INN) or common name ibandronic acid Therapeutic area (MeSH) Osteoporosis, Postmenopausal Anatomical therapeutic chemical (ATC) code M05BA06

### Pharmacotherapeutic group

Drugs for treatment of bone diseases

### Therapeutic indication

Treatment of osteoporosis in post-menopausal women at increased risk of fracture.

A reduction in the risk of vertebral fractures has been demonstrated. Efficacy on femoral-neck fractures has not been established.

## Authorisation details

EMA product number EMEA/H/C/000502 Marketing authorisation holder

Roche Registration Ltd.

6 Falcon Way Shire Park Welwyn Garden City AL7 1TW United Kingdom

Marketing authorisation issued 23/02/2004 Withdrawal of marketing authorisation 14/02/2013 Revision 16

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Bondenza : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (726.29 KB - PDF)

**First published:** 04/09/2009

**Last updated:** 13/05/2013

[View](/en/documents/procedural-steps-after/bondenza-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Bondenza-H-C-502-A20-25 : EPAR - Assessment Report - Article 20

Adopted

Reference Number: EMA/543433/2011

English (EN) (665.37 KB - PDF)

**First published:** 13/09/2011

**Last updated:** 13/05/2013

[View](/en/documents/variation-report/bondenza-h-c-502-a20-25-epar-assessment-report-article-20_en.pdf)

Bondenza-H-C-502-II-22 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (562.31 KB - PDF)

**First published:** 08/03/2010

**Last updated:** 13/05/2013

[View](/en/documents/scientific-discussion-variation/bondenza-h-c-502-ii-22-epar-scientific-discussion-variation_en.pdf)

CHMP post-authorisation summary of positive opinion for Bondenza

Adopted

Reference Number: EMA/821569/2009

English (EN) (502.04 KB - PDF)

**First published:** 17/12/2009

**Last updated:** 13/05/2013

[View](/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-bondenza_en.pdf)

## Initial marketing authorisation documents

Bondenza : EPAR - Procedural steps taken before authorisation

English (EN) (544.75 KB - PDF)

**First published:** 16/10/2006

**Last updated:** 13/05/2013

[View](/en/documents/procedural-steps/bondenza-epar-procedural-steps-taken-authorisation_en.pdf)

#### News on Bondenza (previously Ibandronic Acid Roche)

[European Medicines Agency finalises review of medicines concerned by Roche pharmacovigilance inspection](/en/news/european-medicines-agency-finalises-review-medicines-concerned-roche-pharmacovigilance-inspection) 19/11/2013

[European Medicines Agency starts infringement procedure to investigate Roche's alleged non-compliance with pharmacovigilance obligations](/en/news/european-medicines-agency-starts-infringement-procedure-investigate-roches-alleged-non-compliance-pharmacovigilance-obligations) 23/10/2012

[European Medicines Agency concludes class review of bisphosphonates and atypical fractures](/en/news/european-medicines-agency-concludes-class-review-bisphosphonates-atypical-fractures) 15/04/2011

**This page was last updated on** 13/05/2013

## Share this page

[Back to top](#main-content)